Funding for innovative research to develop and improve animal models, related biological materials, and technologies for studies relevant to human health and disease, aligned with NIH-wide mission.
Funder: National Institutes of Health
Due Dates: February 16, 2027 (New) | March 16, 2027 (Resubmission) | June 16, 2027 (New) | July 16, 2027 (Resubmission) | October 16, 2027 (New) | November 16, 2027 (Resubmission) | January 7, 2028 (Closing)
Funding Amounts: Grants.gov award ceiling: $200,000; project period up to 2 years; no cost sharing required
Summary: Supports exploratory research developing animal models, related materials, technologies, and complementary methodologies relevant to multiple NIH Institutes or Centers.
Key Information: Projects must include animal models and investigate multiple body systems or disease categories; single-disease or single-IC projects are nonresponsive.
This NIH R21 exploratory/developmental program supports innovative research to develop, improve, characterize, and preserve animal models and related biological materials, technologies, and new approach methodologies (NAMs). Run through the Office of Research Infrastructure Programs (ORIP), it also supports better diagnosis, prevention, and treatment of animal diseases that interfere with biomedical research. Its goals include improving the predictability, rigor, reproducibility, and translatability of preclinical studies.
Suitable work includes mammalian and non-mammalian models, animal cell and tissue systems, complementary NAMs, and integrative informatics approaches. Projects must serve research interests across multiple NIH Institutes or Centers and investigate multiple body systems or disease categories. The R21 mechanism favors exploratory work introducing new ideas, systems, or approaches rather than long-term projects or incremental work in established areas.